Simplify Logo

Full-Time

Director – Program Management

Confirmed live in the last 24 hours

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Biopharmaceuticals for eye and infectious diseases

Biotechnology
Healthcare

Compensation Overview

$191.2k - $267.8kAnnually

+ Bonus + Stock Equity + Comprehensive Benefits

Senior, Expert

Irvine, CA, USA

Hybrid work environment.

Category
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s degree in life sciences, bioengineering or related field required.
  • A minimum of 12-15 years of related work experience with a significant amount of experience in a biotech or pharmaceutical background.
  • Experience managing drug development programs from pre-clinical to Phase III studies is essential.
  • Degree in a biopharmaceutical-related field (e.g., biology, chemistry, engineering, etc.)
  • Proficient use of IT / project management tools (Outlook, Excel, MS Project)
  • Established leadership track record with evidence of excellent people management experience, problem solving, collaboration, cross functional leadership and effective communication skills.
  • Excellent communication, influencing, stakeholder management and decision-making skills.
  • Strong project/program management foundation (PMP, PgMP preferred but not required).
Responsibilities
  • Leads cross-functional teams which include CMC, Clinical, Non-Clinical, Regulatory and Commercial, to define product development strategies to meet organizational goals.
  • Provides project management expertise and support for clinical stage drug development programs and works in concert with cross-functional leads to deliver on program plans.
  • Facilitates strategic discussions on scenario planning to enable core team and governance decision making.
  • Manages and leads the budgeting/forecasting process across R&D to ensure achievement of acceptable variances.
  • Continuously monitors pipeline costs and aligns on justification of material cost changes with key stakeholders.
  • Supports development and adherence to budget through pro-active identification and resolution of any program or resource issues.
  • Manages the program dashboard reporting process by working with Program Managers and Program Leads to reflect material program updates.
  • Ability to effectively present program status updates and strategic recommendations to Sr. Management.
  • Direct supervisory responsibilities for a team of high-performing Program Managers with various levels of experience.
  • Provides strong advocacy to support the career development of the PM team.
  • Ensures implementation of effective processes and innovative solutions to support efficiencies in management of programs.
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. The goal of Tarsus Pharmaceuticals is to provide effective medical treatments that improve patient outcomes in areas where there are currently few options.

Company Stage

IPO

Total Funding

$610.6M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

17%

1 year growth

25%

2 year growth

221%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $200 million in non-dilutive financing from Pharmakon Advisors strengthens Tarsus's financial position, enabling further R&D and market expansion.
  • Positive Phase 2a trial results for TP-05 for Lyme Disease prevention indicate promising future product offerings and potential market growth.
  • Recognition through awards like the Zero to Launch Award highlights Tarsus's innovative approach and successful commercialization strategies.

What critics are saying

  • The biopharmaceutical market is highly competitive and capital-intensive, requiring continuous innovation and substantial investment to maintain a competitive edge.
  • Dependence on the success of a limited number of products, such as XDEMVY, makes the company vulnerable to market fluctuations and regulatory changes.

What makes Tarsus Pharamceuticals unique

  • Tarsus Pharmaceuticals focuses on high unmet medical needs in eye care and infectious diseases, setting it apart from competitors with broader but less specialized portfolios.
  • Their flagship product, XDEMVY, is FDA-approved for treating Demodex Blepharitis, a niche condition with limited treatment options, giving them a unique market position.
  • The company's commitment to ethical operations and robust compliance programs ensures trust and reliability among healthcare providers and patients.